Reuterina® Drops Approved Package Insert, August 2009.
Reuterina Junior® Approved Package Insert, July 2010.
Reuterina Daily® Approved Package Insert, July 2010.
Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria, 1-4 October 2001.
Eom T-H, et al. The therapeutic effect of Lactobacillus reuteri in acute diarrhea in infants and toddlers. Korean J Ped 2005;48:986-989.
Chau K, et al. Probiotics for infantile colic: a randomized double-blind placebo controlled trial investigating Lactobacillus reuteri DSM 17938. J Pediatr 2014;166:74-78.
Indrio F, et al. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation. A randomised clinical trial. JAMA Pediatr 2014;168:228-233.
Savino F, et al.Lactobacillus reuteri (American Type Culture Collection Strain 55730) Versus Simethicone in the Treatment of Infantile Colic: A Prospective Randomized Study. Am Acad Pediatrics 2007;119:e124. doi:10.1542/peds.2006-1222.
Szajewska H, et al.Lactobacillus reuteri DSM 17938 for the management of infantile colic in breastfed infants: A randomized, double-blind, placebo-controlled trial. J Pediatr 2013;162:257-262.
Coccorullo P, et al.Lactobacillus reuteri (DSM 17938) in infants with Functional Chronic Constipation: A Double-Blind, Randomised, Placebo-controlled study. The Journal of Paediatrics 2010;157(4):598-602.
Weizman Z, et al. Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: a randomized, double-blind, placebo-controlled trial. J Pediatr 2016;174:160-164.
Gutierrez-Castrellon P, et al. Diarrhea in Preschool Children and Lactobacillus reuteri: A Randomized Controlled Trial. Pediatrics 2014;133:e904–e909. Data on File.
